Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Washington | OTHER |
Not provided
Not provided
This study will test the accuracy of the Hyfe Cough Monitoring System. This system uses a smartwatch to record the number and pattern of coughs (like a "Fitbit for cough").
The investigators will compare the coughs counted by the Hyfe device with manual cough counts from environmental sounds recordings in the same period.
This is a dispersed observational study and will include individuals with a variety of cough related conditions including but not limited to refractory or unexplained cough, Bronchiectasis, COPD, COVID-19, non-tuberculous mycobacterial infection, tuberculosis, or upper respiratory tract infection.
The Hyfe Cough Monitoring System is investigational, which means that it has not been approved by the Food and Drug Administration (FDA). This study is funded by Hyfe, Inc. and executed under the direction of Dr. Peter Small (the Investigator). The study will run until thirty (30) participants have completed the study
The Primary objective is to assess the agreement in cough counting between the Hyfe Cough Monitoring System and human listeners on an hour by hour basis when used by individuals with problematic cough under common living conditions using a Bland-Altman analysis.
The Hyfe Watch, along with the companion app, is part of the Hyfe Cough Monitoring System. It does not compromise the users provacy as it only retains the time of day associated with each cough. When the system detects a short explosive sound, it runs a brief "snippet" of that sound through a cough detection algorithm on the watch. If the algorithm deems the sound to be a cough, the device records the exact time that the cough occurred, and sends this time stamp to the companion app. The companion app does not access any personal information on the phone and is only used to "collect" the times at which a participant coughed from the Hyfe Watch and send them digitally to the researcher.
At the end of the 24 hours monitoring period envisiones, participants will be contacted by video call and asked to download this information from the companion app and send this to the Investigator. The use of the Hyfe Cough Monitoring System will not lead to additional medical interventions or changes to medical care.
In contrast, the sound recording watch will record all ambient sounds during a 24 hour period. This is necessary for the investigator to get an independent count of a participant´s coughing. As such, the sound recording watch will record conversations and those in the participant´s environment during this 24 hour period. It is important to let others in the environment know that sound is being recorded. The recordings will not be directly linked with the participant´s identity and will only be listened to by researchers who are trained in how to ensure the privacy of this data.
The data collected from the sound recording watch will NOT be transferred through the internet while participants are wearing it. Audio recordings will be saved on the actual device. Investigators will download the audio recordings onto a computer after the return the devices. Recordings will then be fully deleted.
Criteria for success:
The goal of this study is to demonstrate the performance of the Hyfe Cough Monitoring System as a device that continually and unobtrusively monitors cough. As has been agreed upon with the FDA, There is no pre-specified performance goal for the HCMS, this information will be reported in the labeling material. Therefore, the success of this study will be judged based on demonstrating adequate precision of our endpoints as quantified by their margin of error. Thus, the study will be considered satisfactory if the following criteria are satisfied:
Bland-Altman analysis:
These 95% Bland-Altman Limits of Agreement (LOA) criteria correspond to the extreme acceptable differences between Hyfe's cough-second counts and those of human annotators; by requiring these limits to have magnitude at most 5, it is expected that most of the differences to have magnitude less than 5. Note that the accompanying criterion for success for the bias is that its confidence interval have endpoints of magnitude at most 0.5, so it is expected that the average difference to be close to 0.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Hyfe Cough Monitoring System | Diagnostic Test | Smartwatch-based cough monitoring |
| Measure | Description | Time Frame |
|---|---|---|
| Hour by hour cough count agreement using Bland Altman | Concordance with human annotators using Bland Altman analysis with 95%CI | 24 hours |
| Measure | Description | Time Frame |
|---|---|---|
| Hour by hour cough count agreement using linear analysis | Concordance with human annotators using linear analysis | 24 hours |
| Event by event cough count analysis | Agreement with human anotators in terms of sensitivity, false positive rate and positive predictive value |
| Measure | Description | Time Frame |
|---|---|---|
| Differential performance of Hyfe day/night | Using Bland Altman Linear analysis Sensitivity, false positive rate and positive predictive value | 24 hours |
| Differential performance of Hyfe between individuals |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Subjects residing in the United States who have problematic coughs due to a variety of etiologies who are willing and able to participate in a decentralized study
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Peter M Small, MD | Hyfe Inc | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hyfe. Inc | Ottawa | Montana | K2B 6R1 | Canada |
De-identified cough counts will be posted publicly in Hyfes GitHub repository
Within one year of study end
Upon contacting the PI with reasonable request
Not provided
Not provided
| ID | Term |
|---|---|
| D003371 | Cough |
| ID | Term |
|---|---|
| D012120 | Respiration Disorders |
| D012140 | Respiratory Tract Diseases |
| D012818 | Signs and Symptoms, Respiratory |
| D012816 | Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
| 24 hours |
Using Bland Altman Linear analysis Sensitivity, false positive rate and positive predictive value
| 24 hours |
| Differential performance of Hyfe between high, middle and low cough rates | Using Bland Altman Linear analysis Sensitivity, false positive rate and positive predictive value | 24 hours |
| D013568 | Pathological Conditions, Signs and Symptoms |